← Open Payments lookup

CHRISTIEN OLEWNICZAK: Open Payments

NPI 1609498658 · LANCASTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,318 in 166 payments from 19 companies in 2025. Trend: 2023 $2,936 · 2024 $3,582 · 2025 $4,318

Food & beverage: $4,315Education: $4
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)33$868
Vanda Pharmaceuticals Inc.20$654
Teva Pharmaceuticals USA, Inc.32$606
ABBVIE INC.32$386
Otsuka America Pharmaceutical, Inc.11$379
Alkermes, Inc.7$298
AstraZeneca Pharmaceuticals LP6$249
Axsome Therapeutics, Inc.4$174
Luye Pharma (USA) Ltd.6$162
E.R. Squibb & Sons, L.L.C.1$125

Products named: CAPLYTA, FANAPT, AUSTEDO XR, VRAYLAR, REXULTI, FARXIGA, Auvelity, ARISTADA.

Industry payments across NY — which companies pay providers there.